Description

Primobolan 25 mg by Swiss Healthcare contains Methenolone Acetate, an oral anabolic-androgenic steroid (AAS) historically utilized in clinical settings for the treatment of muscle wasting, osteoporosis, and severe weight loss. Known for its mild androgenic profile and strong anabolic effects, Primobolan is ideal for research focused on muscle preservation, nitrogen retention, and tissue regeneration with minimal side effects.

Unlike many oral AAS compounds, Methenolone Acetate is not 17-alpha alkylated, making it considerably gentler on the liver. Its low estrogenic and androgenic activity profile makes it highly suitable for studies that require anabolic activity without water retention, gynecomastia, or significant hormonal disruption.

Swiss Healthcare manufactures this compound under pharmaceutical-grade standards. Each bottle contains 40 tablets, each delivering a consistent 25 mg dose of Methenolone Acetate for precise control in experimental environments.

Product Details

• Active Ingredient: Methenolone Acetate

• Concentration per Tablet: 25 mg

• Form: Oral tablets

• Package Size: 40 tablets per bottle

Pharmacokinetics

Methenolone Acetate has a half-life of approximately 4–6 hours, making multiple daily doses ideal for consistent blood levels in research studies. Its non-hepatotoxic nature and lack of estrogenic activity distinguish it from other oral anabolic agents.

Usage Recommendations

• Typical Research Dosage (historical reference): 50–100 mg per day, divided into 2–3 doses

• Current Use: Intended solely for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption or therapeutic application. Not suitable for individuals under 18, pregnant or breastfeeding women, or anyone with underlying health conditions. Must be used in accordance with all local laws and scientific handling protocols.